Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy
Hypoxic-ischaemic encephalopathy (HIE) is a severe complication of asphyxia at birth. Therapeutic hypothermia, the standard method for HIE prevention, is effective in only 50% of the cases. As the understanding of the immunological basis of these changes increases, experiments have begun with the us...
Saved in:
Main Authors: | Izabela Zdolińska-Malinowska, Dariusz Boruczkowski, Dominika Hołowaty, Paweł Krajewski, Emilian Snarski |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2022/9125460 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wharton’s Jelly Mesenchymal Stem Cell Administration Improves Quality of Life and Self-Sufficiency in Children with Cerebral Palsy: Results from a Retrospective Study
by: Dariusz Boruczkowski, et al.
Published: (2019-01-01) -
Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy in Sub-Saharan Africa: A scoping review.
by: Naa A Buxton-Tetteh, et al.
Published: (2025-01-01) -
Hypoxic-Ischemic Encephalopathy: Impact on Retinal Neurovascular Integrity and Function
by: Ismail S. Zaitoun, et al.
Published: (2021-07-01) -
Commentary on the published position statement regarding the pathogenesis of fetal basal ganglia- thalamic hypoxic-ischaemic injury
by: J Anthony, et al.
Published: (2023-12-01) -
Temporal dynamics of neonatal hypoxic–ischemic encephalopathy injuries on magnetic resonance imaging
by: Holly Flyger, et al.
Published: (2025-11-01)